Analysts expect Prime Medicine, Inc. to report revenue of 1.39 M for Q3 26, against a range of 1.30 M to 1.48 M. The most recent reported quarter, Q2 26, came in at 1.15 M, a 50.5% miss against the 2.32 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 204,500.00 | 2.19 M | 1.45 M | 1.11 M | 1.23 M | 842,000.00 | 856,000.00 | 1.15 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 7.96 M | 12.17 M | 5.22 M | 4.25 M | 2.93 M | 1.45 M | 2.50 M | 2.49 M | 1.48 M | 6.35 M | 1.32 M | 1.30 M | 1.79 M | 6.35 M | 4.09 M | 3.75 M | ||||||||||
| Low Estimate | 6.82 M | 10.09 M | 4.37 M | 3.65 M | 2.51 M | 1.27 M | 2.28 M | 2.16 M | 1.30 M | 5.45 M | 1.22 M | 1.07 M | 1.63 M | 5.55 M | 3.47 M | 3.44 M | ||||||||||
| Consensus Estimate | 7.39 M | 11.13 M | 4.80 M | 3.95 M | 2.72 M | 1.36 M | 2.39 M | 2.32 M | 1.39 M | 5.90 M | 1.27 M | 1.19 M | 1.71 M | 5.95 M | 3.78 M | 3.59 M |
Analysts expect Prime Medicine, Inc. to report earnings per share of -0.23 for Q3 26, against a range of -0.24 to -0.22. The most recent reported quarter, Q2 26, came in at -0.24, a 11.1% beat against the -0.27 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.44 | -0.31 | -0.40 | -0.41 | -0.32 | -0.22 | -0.28 | -0.24 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.35 | -0.36 | -0.29 | -0.31 | -0.23 | -0.24 | -0.23 | -0.26 | -0.22 | -0.20 | -0.26 | -0.25 | -0.18 | -0.17 | -0.26 | -0.24 | ||||||||||
| Low Estimate | -0.37 | -0.38 | -0.35 | -0.35 | -0.25 | -0.28 | -0.25 | -0.28 | -0.24 | -0.24 | -0.30 | -0.29 | -0.20 | -0.19 | -0.28 | -0.28 | ||||||||||
| Consensus Estimate | -0.36 | -0.37 | -0.32 | -0.33 | -0.24 | -0.26 | -0.24 | -0.27 | -0.23 | -0.22 | -0.28 | -0.27 | -0.19 | -0.18 | -0.27 | -0.26 |
Pull Wall Street consensus for Prime Medicine, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PRME&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PRME", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PRME&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();